Products

What will AGI do for Amiquinsin hydrochloride?

This classification denotes an antihypertensive agent with the molecular formula C11H12N2O2.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EZ270U8Z9W, chemically known as 4-quinolinamine, 6,7-dimethoxy-, monohydrochloride, monohydrate but more generally known as amiquinsin hydrochloride, which bears US NIH Compound Identifier 23509. Most nations, for tariff and trade purposes, schedule amiquinsin hydrochloride under HS 29334990 and SITC 51575. As of Q4 2014, AMIQUINSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Amiquinsin hydrochloride bears US NLM identifiers UMLS ID C0953995 and NCI Concept Code C75237. SMILES: COC1CC2C(CCNC2CC1OC)N.O.CL.

How AGI delivers it

Four ways AGI delivers for Amiquinsin hydrochloride

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amiquinsin hydrochloride, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amiquinsin hydrochloride, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amiquinsin hydrochloride connects

measured by

  • Active Ingredient Potencymodel
  • Chloride Contentmodel
  • Compound Puritymodel
  • Crystal Form Polymorphmodel